hit counter
Arena Pharmaceuticals, Inc. (ARNA) Stock News Sentiment & Price - Sentifly
ARNA - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Arena Pharmaceuticals, Inc. (ARNA)

USA
Biotechnology
NASDAQ
ARNA Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ARNA Latest news
Business Wire
Neutral
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-10-21 16:05

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options and inducement restricted stock units ("RSUs") to new employees. The inducement stock options and RSUs were approved by the Compensation Committee on October 5, 2021 and each have a grant date and vesting commencement date (if applicable) of October 15, 2021, and were granted as inducements material to the new emp

Business Wire
Neutral
Arena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4
2021-10-14 16:05

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena Pharmaceuticals, Inc. will release its third quarter 2021 financial results and provide a corporate update on Thursday, November 4, 2021.

Seeking Alpha
Positive
Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout
2021-10-14 08:44

After the recent FDA black box warning of JAKi, Arena Pharmaceuticals' share price has rallied recovering some of its 2021 losses. In this article, Etrasimod's ulcerative colitis phase 2 data will be analyzed and explain what our views for the S1P-R class moving forward.

Business Wire
Neutral
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-09-17 16:05

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 20 new employees inducement stock options to purchase an aggregate of 33,340 shares of its common stock and 15,655 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of September 15, 2021 and were granted as inducements material to the new employees entering

InvestorPlace
Positive
7 Busted Biotech Stocks Due for a Rebound
2021-09-08 12:25

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on InvestorPlace.

Business Wire
Neutral
Arena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor Conferences
2021-09-02 08:30

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena to host two virtual R&D Investor calls for analysts and investors focused on etrasimod programs in gastroenterology and dermatology.

Business Wire
Neutral
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-08-18 16:05

PARK CITY, Utah--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options, inducement performance restricted stock units ("PRSUs"), and inducement restricted stock units ("RSUs") to new employees. The inducement stock options, PRSUs, and RSUs each have a grant date and vesting commencement date (if applicable) of August 15, 2021, and were granted as inducements material to the new emplo

Seeking Alpha
Neutral
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2021 Results - Earnings Call Transcript
2021-08-05 22:58

Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Negative
Arena Pharmaceuticals, Inc. (ARNA) Reports Q2 Loss, Lags Revenue Estimates
2021-08-05 20:32

Arena Pharmaceuticals, Inc. (ARNA) delivered earnings and revenue surprises of -8.60% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Business Wire
Neutral
Arena Reports Second Quarter Financial Results and Key Program Updates
2021-08-05 16:05

PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ARNA--Arena Pharmaceuticals (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.

Loading more news...